1-6 of 6
Rolf Ljung, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Predicting Thrombosis Recurrence in Children: The Role of Thrombophilia Testing

Bader Allahyani, MD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2020) 136 (Supplement 1): 2–3.
https://doi.org/10.1182/blood-2020-133384
Published: 2020
Journal Articles

Pulmonary Embolism in Children with Asymptomatic Proximal Deep Vein Thromboembolism: Single-Center Experience from Sweden

Bader Allahyani, MD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2020) 136 (Supplement 1): 4.
https://doi.org/10.1182/blood-2020-133289
Published: 2020
Journal Articles

Venous Thromboembolism in Children 0-18 Years — a Regional Population-Based Study from Sweden

Bader Allahyani, MD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 3805.
https://doi.org/10.1182/blood-2018-99-113844
Published: 2018
Journal Articles

99.3% of Inhibitors in Severe Hemophilia a Develop before Exposure Day 75. Time to Change Definition of Previously Treated Patients; Data from 1038 Patients with Severe Hemophilia a of the Pednet Registry

Marijke Van den Berg, MD PhD, Kathelijn Fischer, Elena Santagostino, Herve Chambost, Karin Kurnik, Gili Kenet, MD, Christoph Male, MD, Anne Rafowicz, Helen Platokouki, Susanna Ranta, MD PhD, Christel Van Geet, MD, Johannes Oldenburg, Ri Liesner, Segolene Claeyssens, MD, Nadine Gretenkort-Andersson, Anne Mäkipernaa, PhD, Torben Stamm Mikkelsen, Manuel Carcao, Beatrice Nolan, Liz Chalmers, A.R. Cid, Teresa Álvarez-Roman, Carmen Altisent, Georges Rivard, MD FRCPC, Claudio Molinari, Martina Buehrlen, Rainer Kobelt, Carmen Escuriola, Manuela Carvalho, Christoph Koenigs, MD PhD, Mike Williams, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 2472.
https://doi.org/10.1182/blood-2018-99-114518
Published: 2018
Journal Articles

Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B

Yasmina L. Abajas, MD, Paul Edward Monahan, MD, Brenda Nielsen, RN, Pia Petrini, MD, Susanna Ranta, MD PhD, Geoffrey A. Allen, MD, Silvia Horneff, MD, Annika Martensson, MD PhD, Johannes Oldenburg, MD PhD, Rolf Ljung, MD PhD Professor
Journal: Blood
Blood (2018) 132 (Supplement 1): 1193.
https://doi.org/10.1182/blood-2018-99-120141
Published: 2018
Journal Articles

Risk Factors for the Development of High-Titer Inhibitors in 260 Children with Severe Hemophilia a Born Between 1990 and 2009: The Remain Study

Maria Elisa Mancuso, MD PhD, Kathelijn Fischer, MD PhD MSc, Elena Santagostino, MD PhD, Johannes Oldenburg, Prof, Helen Platokouki, MD, Christoph Königs, MD PhD, Carmen Escuriola, MD, Georges-Etienne Rivard, MD, Ana Cid, MD, Manuel Carcao, MD, Rolf Ljung, MD PhD, Pia Petrini, MD, Anne Rafowicz, MD, Carmen Altisent, MD, Gili Kenet, MD, Raina Liesner, Karin Kurnik, MD, Christel Van Geet, MD PhD, Teresa Alvarez-Roman, MD, Tin Tin Yee, MD, Guenter Auerswald, Sr., MD, Rosario Perez-Garrido, MD, Beatrice Nolan, Hervé Chambost, Anne Makipernaa, MD, Angelo Claudio Molinari, MD, Angela Thomas, MBBS, PhD, Elizabeth Chalmers, MD, Mike Williams, MD, Rainer Kobelt, MD, Marijke Van den Berg, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3774.
https://doi.org/10.1182/blood.V128.22.3774.3774
Published: 2016